Publications

2021

Luo B, Jin MM, Li X, Makunga NP, Hu X. Yeast Surface Display for Biosynthetic Pathway Reconstruction. ACS Synth Biol. 2021;10(11):2938-2946.
Tung C-, Han MS, Shen Z, Gray BD, Pak KY, Wang J. Near-Infrared Fluorogenic Spray for Rapid Tumor Sensing. ACS Sens. 2021;6(10):3657-3666.
Aboushady Y, Gabr M, ElHady AK, Salah M, Abadi AH, Wilms G, et al. Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases. ACS Chem Neurosci. 2021;12(22):4302-4318.
Cheal SM, Patel M, Yang G, Veach DR, Xu H, Guo H-, et al. Correction to An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy. Bioconjug Chem. 2021;32(2):394.
Kelly JM, Amor-Coarasa A, Sweeney E, Wilson JJ, Causey PW, Babich JW. A suitable time point for quantifying the radiochemical purity of Ac-labeled radiopharmaceuticals. EJNMMI Radiopharm Chem. 2021;6(1):38.
Chen X, Lee SK, Song M, Zhang T, Han MS, Chen Y-, et al. RHAMM-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment. Mol Ther Oncolytics. 2021;23:277-287.
Egan CE, Stefanova D, Ahmed A, Raja VJ, Thiesmeyer JW, Chen KJ, et al. CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer. Thyroid. 2021;31(10):1481-1493.
Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, et al. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications. Bioconjug Chem. 2021;32(4):649-654.
Zhang W, Du B, Gao M, Tung C-. A Hybrid Nanogel to Preserve Lysosome Integrity for Fluorescence Imaging. ACS Nano. 2021;15(10):16442-16451.

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065